Cargando…
Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients
Chronic kidney disease (CKD) is a public health problem with very high prevalence and mortality. Yet, there is a paucity of effective treatment options, partly due to insufficient knowledge of underlying pathophysiology. We combined metabolomics (GCMS) with kidney gene expression studies to identify...
Autores principales: | Hallan, Stein, Afkarian, Maryam, Zelnick, Leila R., Kestenbaum, Bryan, Sharma, Shoba, Saito, Rintaro, Darshi, Manjula, Barding, Gregory, Raftery, Daniel, Ju, Wenjun, Kretzler, Matthias, Sharma, Kumar, de Boer, Ian H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832558/ https://www.ncbi.nlm.nih.gov/pubmed/29128444 http://dx.doi.org/10.1016/j.ebiom.2017.10.027 |
Ejemplares similares
-
Changes in TCA cycle and TCA cycle-related metabolites in plasma upon citric acid administration in rats
por: Hara, Yurie, et al.
Publicado: (2021) -
High-Density Lipoprotein Lipidomics and Mortality in CKD
por: Lidgard, Benjamin, et al.
Publicado: (2023) -
Gene Expression Studies and Targeted Metabolomics Reveal Disturbed Serine, Methionine, and Tyrosine Metabolism in Early Hypertensive Nephrosclerosis
por: Øvrehus, Marius A., et al.
Publicado: (2018) -
Metabolic Differences in Diabetic Kidney Disease Patients with Normoalbuminuria versus Moderately Increased Albuminuria
por: Hallan, Stein I., et al.
Publicado: (2023) -
Vitamin D Metabolic Ratio and Risks of Death and CKD Progression
por: Bansal, Nisha, et al.
Publicado: (2019)